Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 1, 2010

Gen-Probe’s Panther MDx System CE Marked and Launched in Europe

Gen-Probe’s Panther MDx System CE Marked and Launched in Europe

Initial tests for the system include Aptima assays for gonorrhea and chlamydia.[Stefan Rajewski-Fotolia.com]

  • Gen-Probe has been granted a CE mark for its automated molecular diagnostics system, Panther™. Tests initially available for use with Panther include the sexually transmitted infection assays, Aptima Combo 2®, Aptima CT (chlamydia), and Aptima GC (gonorrhea) assays. A number of other qualitative and quantitative assays are also in development, Gen-Probe notes. Panther will be launched immediately in Europe but has yet to be sanctioned by FDA for commercialization in the U.S., the firm adds.

    Panther has been designed as a “sample-in-result-out” instrument that fully automates all aspects of nucleic acid testing for small- to medium-sized laboratories. Developed to build on the success of Gen-Probe’s existing Tigris® system for large diagnostics laboratories, the Panther platform reportedly allows a single operator to process 275 samples in eight hours, with just one hour of hands-on time. For higher throughput the system is capable of processing 500 samples in 12 hours, Gen-Probe states.

    Panther has been over three years in development, and European launch has been achieved a month ahead of schedule, remarks Carl Hull, Gen-Probe president and CEO. “We believe the Panther system will revolutionize molecular diagnostics by offering customers high levels of productivity and instrument flexibility that were once reserved for high-throughput clinical chemistry and immunoassay systems.”



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »